N-Isopropylatropine en es it fr

N-Isopropylatropine Brand names, N-Isopropylatropine Analogs

N-Isopropylatropine Brand Names Mixture

  • Combivent Inhalation Aerosol (Ipratropium Bromide + Salbutamol Sulfate)
  • Combivent Inhalation Solution (Ipratropium Bromide + Salbutamol Sulfate)
  • Duovent Udv (Fenoterol Hydrobromide + Ipratropium Bromide)
  • Ratio-Ipra Sal Udv (Ipratropium Bromide + Salbutamol Sulfate)

N-Isopropylatropine Chemical_Formula


N-Isopropylatropine RX_link


N-Isopropylatropine fda sheet

N-Isopropylatropine FDA

N-Isopropylatropine msds (material safety sheet)

N-Isopropylatropine Synthesis Reference

K. Zeile et al.,U.S. Pat. 3,505,337 (1970)

N-Isopropylatropine Molecular Weight

332.457 g/mol

N-Isopropylatropine Melting Point


N-Isopropylatropine H2O Solubility

Freely soluble

N-Isopropylatropine State


N-Isopropylatropine LogP

No information avaliable

N-Isopropylatropine Dosage Forms

Aerosol (with propellants); Liquid; Metered-dose (aerosol); Metered-dose (pump); Solution

N-Isopropylatropine Indication

For maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

N-Isopropylatropine Pharmacology

Ipratropium bromide, a synthetic ammonium compound structurally similar to atropine, is used as a bronchodilator in the management of cholinergic-mediated bronchospasm associated with chronic obstructive pulmonary disease and in the treatment of rhinorrhea associated with the common cold or with allergic or nonallergic seasonal rhinitis.

N-Isopropylatropine Absorption

Inhalation (local)-minimal; Nasal-rapid and minimal

N-Isopropylatropine side effects and Toxicity

LD50=1001mg/kg (orally in mice)

N-Isopropylatropine Patient Information

N-Isopropylatropine Organisms Affected

Humans and other mammals